Related Experiment Video
Updated: Sep 4, 2025
04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
813
Primary dural lymphoma: Case report
Jihane Saidy1, Abderrazzak Bertal1, Saad Hmada1
1Neurosurgery Department, University Hospital Center IBN ROCHD, Casablanca, Morocco.
Annals of Medicine and Surgery (2012)
|July 21, 2022
Summary
Primary dural lymphoma (PDL) is a rare condition in immunocompetent individuals, often mimicking other brain tumors. Early diagnosis and combined treatment are crucial for favorable outcomes.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Primary dural lymphoma (PDL) is an uncommon neoplastic proliferation of lymphocytes arising from the dura mater.
- PDL can present insidiously and mimic more frequent intracranial pathologies, posing diagnostic challenges.
Observation:
- A case is presented of a patient with intracranial hypertension syndrome.
- Initial brain MRI revealed a mass suspected to be a meningioma.
- Surgical exploration uncovered an occult mass, later diagnosed as PDL via immunohistochemistry.
Findings:
- The case underscores the rarity of PDL in immunocompetent patients.
- Histopathological examination and immunohistochemistry confirmed the diagnosis of PDL.
- The study highlights the importance of considering PDL in the differential diagnosis of dural-based masses.
Implications:
- Accurate diagnosis of PDL is critical for appropriate management.
- Combined surgical resection and adjuvant chemoradiation offer good clinical outcomes for PDL.
- This case emphasizes the need for a multidisciplinary approach in managing rare dural tumors.
